Caligan Partners LP

Holdings History for Avalo Therapeutics, Inc. - COMMON STOCK (AVTX)

Symbol: AVTX on Nasdaq
Investment type: Equity / COMMON STOCK
Latest Disclosed Shares Owned: 881,533 shares
Security Ownership %: 4.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Caligan Partners LP ownership in Avalo Therapeutics, Inc. COMMON STOCK (AVTX)

17 Feb 2026 - Caligan Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 881,533 shares of Avalo Therapeutics, Inc. COMMON STOCK (AVTX). This represents 4.9% ownership of the company. In their previous filing dated 14 Nov 2025, Caligan Partners LP had reported owning 833,333 shares, indicating an increase of +5.8%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Caligan Partners LP	4.9%	-23%	$14,941,984	881,533	+48,200	+5.8%	$16.95	13G/A	31 Dec 2025	17 Feb 2026, 17:00
Caligan Partners LP	6.3%		$10,591,662	833,333			$12.71	13G	30 Sep 2025	14 Nov 2025, 14:31

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		1.5%	+0.08%	$16,008,639	881,533	+48,200	+5.8%	$18.16	Q4 2025
30 Sep 2025		1.5%	+1.5%	$10,591,662	833,333	+833,333	NEW	$12.71	Q3 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.